The US Supreme Court declined to hear former pharmaceutical company CEO Martin Shkreli's challenge to a $64.6 million financial penalty imposed by a judge after he raised a lifesaving drug's price by more than 4,000% https://t.co/IrCDUhDSlB
🆕 from @AARPMedia: AARP reacts to first Medicare-negotiated Rx prices.
👏 “Today’s announcement marks a significant step forward in our long-standing efforts to lower prescription drug prices.” - @NancyLeaMond
📰 Read more: https://t.co/bALYQ4Z3lC
#AARPNY delivered 4,000+ letters to @CarlHeastie’s #Bronx office today urging him to put prescription drug importation bill to a vote in #NYSAssembly to OK safe import of #Rx to NYS. Time is running out on 2024 session. NY needs action now! #FairRxPricesNow
@hborrud If they are, they should be documenting everything exceedingly well so that it can be shown that the funds went to an activity legal for a c3.